Global Seborrheic Keratosis Treatment Market 2019-2023
SKU ID : TNV-14098792 | Publishing Date : 27-Mar-2019 | No. of pages : 112
Detailed TOC of Global Seborrheic Keratosis Treatment Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY TYPE
• Market segmentation by type
• Comparison by type
• Cryotherapy - Market size and forecast 2018-2023
• Electrocautery - Market size and forecast 2018-2023
• Other treatments - Market size and forecast 2018-2023
• Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2018-2023
• Europe - Market size and forecast 2018-2023
• Asia - Market size and forecast 2018-2023
• ROW - Market size and forecast 2018-2023
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Aclaris Therapeutics, Inc.
• Brymill Cryogenic Systems
• CryoConcepts LP
• OLYMPUS CORPORATION
• Special Medical Technology Co., Ltd.
PART 13: APPENDIX
• Research methodology
• List of abbreviations
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: - Market share 2018-2023 (%)
Exhibit 18: Comparison by type
Exhibit 19: Cryotherapy - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Cryotherapy - Year-over-year growth 2019-2023 (%)
Exhibit 21: Electrocautery - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Electrocautery - Year-over-year growth 2019-2023 (%)
Exhibit 23: Other treatments - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Other treatments - Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by type
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
Exhibit 31: Top 3 countries in North America
Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 34: Top 3 countries in Europe
Exhibit 35: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 37: Top 3 countries in Asia
Exhibit 38: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 40: Top 3 countries in ROW
Exhibit 41: Market opportunity
Exhibit 42: Growth in geriatric population 2013-2017 (%)
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Vendor landscape
Exhibit 45: Landscape disruption
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Market positioning of vendors
Exhibit 49: Aclaris Therapeutics, Inc. - Vendor overview
Exhibit 50: Aclaris Therapeutics, Inc. - Business segments
Exhibit 51: Aclaris Therapeutics, Inc. - Organizational developments
Exhibit 52: Aclaris Therapeutics, Inc. - Segment focus
Exhibit 53: Aclaris Therapeutics, Inc. - Key offerings
Exhibit 54: Aclaris Therapeutics, Inc. - Key customers
Exhibit 55: Brymill Cryogenic Systems - Vendor overview
Exhibit 56: Brymill Cryogenic Systems - Key offerings
Exhibit 57: Brymill Cryogenic Systems - Key customers
Exhibit 58: CryoConcepts LP - Vendor overview
Exhibit 59: CryoConcepts LP - Key offerings
Exhibit 60: CryoConcepts LP - Key customers
Exhibit 61: OLYMPUS CORPORATION - Vendor overview
Exhibit 62: OLYMPUS CORPORATION - Business segments
Exhibit 63: OLYMPUS CORPORATION - Organizational developments
Exhibit 64: OLYMPUS CORPORATION - Geographic focus
Exhibit 65: OLYMPUS CORPORATION - Segment focus
Exhibit 66: OLYMPUS CORPORATION - Key offerings
Exhibit 67: OLYMPUS CORPORATION - Key customers
Exhibit 68: Special Medical Technology Co., Ltd. - Vendor overview
Exhibit 69: Special Medical Technology Co., Ltd. - Key offerings
Exhibit 70: Special Medical Technology Co., Ltd. - Key customers
Exhibit 71: Validation techniques employed for market sizing
Keyplayers in Global Seborrheic Keratosis Treatment Market 2019-2023
Aclaris Therapeutics, Inc.Brymill Cryogenic Systems
CryoConcepts LP
OLYMPUS CORPORATION
Special Medical Technology Co., Ltd.